4
Changes in Ownership
BioXcel Therapeutics, Inc. Filed Acc 0001104659-22-034508
Options or other derivatives
- Chief Medical Officer acquired 8,337 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
O'Neill Vincent · Chief Medical Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-14 | Grant or award : show line 1 in the form Restricted Stock Units | +8,337 | 8,337 | D |
Loading xslF345X03/tm229449-5_4seq1.xml…